Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 2.02, 7.01, 9.01 · 8-K

Core Laboratories Inc.

CLBNYSEEQUITYCurrent

Results of Operations and Financial Condition · Regulation FD Disclosure

Item 2.02 Results of Operations and Financial Condition. On July 29, 2026, Core Laboratories Inc. issued a press release announcing its financial results for the second quarter of 2026.

Filed Jul 29, 2026Accepted Jul 29, 2026, 4:43 PM EDTCIK 1958086Accession 0001193125-26-324101
Share

Company context

Current securities

Recent company filings

  1. SCHEDULE 13G/A - filed by DISCIPLINED GROWTH INVESTORS INC /MN regarding Core Laboratories Inc. /DE/Nov 16, 2026
  2. SCHEDULE 13G/A - filed by EARNEST PARTNERS LLC regarding Core Laboratories Inc. /DE/Nov 13, 2026
  3. 10-Q filingOct 30, 2026
  4. Results of Operations and Financial Condition · Regulation FD DisclosureOct 28, 2026
  5. 4 filingOct 5, 2026

Registered securities in this filing

CORE LABORATORIES INC. · 8-K · Filed 2026-07-29

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock (par value $0.01)

Symbol
CLB
Exchange
NYSE
Classification
COMMON
Status
Current
Filing context

Context: C_bc46003b-2cbb-40aa-ae2c-bc7b4b03ced6

Dimensions: Not supplied

Accession 000119312526324101 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 2.02, 7.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 2.02Item 2.02 - Results of Operations
Item 2.02 Results of Operations and Financial Condition. On July 29, 2026, Core Laboratories Inc. issued a press release announcing its financial results for the second quarter of 2026.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On July 29, 2026, Core Laboratories Inc. issued a press release announcing a quarterly cash dividend of $0.01 per share of common stock for shareholders of record on August 10, 2026 and payable August 31, 2026. The full text of the press release is set forth in Exhibit 99.1 attached hereto. The information in this Report and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly stated by specific reference in such filing.
Filed exhibits (1)
EX-99.1 (by filename) clb-ex99_1.htm

EX-99.1 2 clb-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE CORE LAB REPORTS SECOND QUARTER 2026 RESULTS: • REVENUE OF $124.6 MILLION, UP 2% SEQUENTIALLY AND DOWN 4% YEAR-OVER-YEAR • OPERATING INCOME OF $9.2 MILLION; EX-ITEMS, $9.4 MILLION, UP 42% SEQUENTIALLY AND DOWN 36% YEAR-OVER-YEAR • GAAP EARNINGS PER SHARE OF $0.13; EPS EX-ITEMS OF $0.11, UP 85% SEQUENTIALLY AND DOWN 42% YEAR-OVER-YEAR • FREE CASH FLOW OF $3.1 MILLION • COMPANY REPURCHASED 214,712 SHARES OF COMMON STOCK, FOR $2.7 MILLION AGGREGATE PURCHASE PRICE • COMPANY ANNOUNCES Q3 2026 QUARTERLY DIVIDEND HOUSTON (July 29, 2026) - Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported second quarter 2026 revenue of $124,600,000. Core’s operating income was $9,200,000, with earnings per diluted share (“EPS”) of $0.13, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $9,400,000, yielding operating margins of 8%, and EPS, ex-items, of $0.11. A full reconciliation of non-GAAP financial measures is included in the attached financial tables. Core’s CEO, Larry Bruno, stated, “Ou…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.